About Indica Labs
Indica Labs is the global leader in AI-powered digital pathology, redefining medicine with comprehensive pathology platforms that support the entire translational journey from basic science research to clinical diagnostics. The company's flagship HALO software suite integrates image management and quantitative image analysis to deliver standardized, reproducible tissue-based analysis at every stage of drug development and patient care. Founded to advance pathology through artificial intelligence, Indica Labs serves research institutions, pharmaceutical companies, clinical laboratories, and diagnostic centers worldwide. The company's solutions span from HALO AI for trainable AI in research settings to HALO AP Dx, an FDA-cleared case-centric pathology platform enabling primary diagnosis and remote working in anatomic pathology. Their clinical AI portfolio includes CE-IVD marked tools for prostate cancer detection and Gleason grading, breast IHC biomarker quantification (HER2, ER, PR, Ki67), lung PD-L1 expression analysis, and slide quality control. Indica Labs has achieved deployments across all top 20 pharmaceutical companies and maintains a global presence with employees in 12 countries. The company's technology has been utilized in thousands of peer-reviewed publications and is deployed in laboratories around the world. Their comprehensive service offerings include AI-powered companion diagnostics development, pharma services, AWS-hosted cloud services, and integration and migration support. With enterprise-grade security, flexible deployment options (on-premise or cloud), and seamless integration with existing laboratory information systems, Indica Labs delivers end-to-end digital pathology workflows that improve diagnostic accuracy, efficiency, and patient care.
Mission & Story
Mission
Redefining medicine with pathology platforms supporting life science discovery, translational research, clinical workflows, and companion diagnostic development
Clinical Focus
Medical conditions and clinical areas addressed by Indica Labs.
Who It Serves
Milestones & Awards
Recent Milestones
FDA clearance for HALO AP Dx, CE-IVDR marking for HALO AP, deployment across all top 20 pharma companies, Best in KLAS award, AI-powered companion diagnostics offering unveiled ahead of ASCO
Awards & Recognition
Best in KLAS Report - Top Score for Enterprise Platform
Key Partnerships
Social & Media
Latest Updates
Indica Labs Expands into Prostate Cancer, Improving NGS ConfidenceThrough Precise Tumor Quantification
What is new in HALO®, HALO AI, and HALO Link 4.3?
Lab Logic Brings Intelligent Case Orchestration to HALO AP® and HALO AP Dx
Integrated Spatial Multiomics Pipeline For Visualizing Protein Interactions In The Tumor Microenvironment
HALO AP 2.5: Scaling Digital Pathology with Intelligent Workflow Orchestration
Company Details
- Founded
- 2011
- Headquarters
- Albuquerque, NM, USA
- Employees
- 51-200
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 45 →
Aiforia
Aiforia provides AI-powered digital pathology solutions for clinical diagnostics and research. The company offers cloud-based deep learning tools and CE-IVD marked clinical suites for analyzing pathology images across multiple cancer types, serving pathologists, researchers, and diagnostic laboratories worldwide.
Aignostics
Aignostics develops AI-powered pathology solutions for precision medicine, specializing in tumor microenvironment analysis from H&E-stained whole slide images. The company serves life sciences companies and academic researchers with foundation models and custom analytics services.
Aiosyn
Aiosyn develops AI-powered computational pathology software that integrates into standard digital pathology workflows. The company specializes in deep learning solutions for cancer and chronic kidney disease diagnostics, serving clinical laboratories, biopharma, and CROs.
AIxMed
AIxMed develops AI-powered computational cytology platforms for cancer detection and diagnosis. The company's flagship product AIxURO analyzes urine cytology for bladder cancer, with additional platforms in development for thyroid, cervical, and lung cancer screening.
Akoya Biosciences
Akoya Biosciences, now part of Quanterix, provides spatial biology solutions for high-plex tissue analysis. The company develops instruments, assays, and software for spatial proteomics research, enabling researchers to map biomarkers at single-cell resolution in tissue samples.
Caris Life Sciences
Caris Life Sciences is a leading precision medicine company that provides comprehensive molecular profiling for cancer patients. The company combines genomic, transcriptomic, and proteomic data with AI to deliver personalized treatment insights for oncologists and patients.
CellaVision
201-500 employees
CellaVision is a world-leading provider of digital hematology microscopy solutions covering analyzers, instruments, reagents, and software. The company automates workflows in hematology laboratories of all sizes for human and animal blood and body fluid sample analysis.
Clever Culture Systems
Clever Culture Systems develops AI-powered automated microbiology culture plate reading technology for pharmaceutical and clinical laboratories. Their flagship product, APAS Independence, automates the imaging, interpretation, and reporting of microbial growth on culture plates.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.